CISPLATIN for Diffuse large b-cell lymphoma refractory: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 109 adverse event reports in the FDA FAERS database where CISPLATIN was used for Diffuse large b-cell lymphoma refractory.

Most Reported Side Effects for CISPLATIN

Side Effect	Reports	%	Deaths	Hosp.
Off label use	4,359	9.2%	746	1,415
Disease progression	3,746	7.9%	880	500
Neutropenia	3,095	6.5%	464	920
Febrile neutropenia	3,010	6.3%	580	1,580
Nausea	2,923	6.2%	282	1,470
Drug ineffective	2,608	5.5%	744	607
Thrombocytopenia	2,565	5.4%	410	911
Anaemia	2,530	5.3%	338	1,111
Vomiting	2,326	4.9%	286	1,314
Diarrhoea	2,022	4.3%	376	1,069
Malignant neoplasm progression	2,004	4.2%	726	446
Pyrexia	1,863	3.9%	243	1,263
Myelosuppression	1,849	3.9%	106	843
Acute kidney injury	1,783	3.8%	279	1,162
Fatigue	1,394	2.9%	161	561